drugset / Trial / NCT04687566
Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Amphetamine Addiction
Phase 2/3
Unknown
120 enrolled
National Cheng-Kung University Hospital
Ministry of Science and Technology, Taiwan · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The investigators will conducted a randomized double-blind placebo-controlled study to investigate the treatment outcomes of add-on low dose dextromethorphan (DM), memantine (MM), or dextromethorphan and memantine combination (DM+MM) in amphetamine-type stimulants use disorder patients.
Timeline
- Start
- 2020-08-11
- Primary completion
- 2024-07-31
- Completion
- 2024-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dextromethorphan | Unknown | 60 mg | — |
| Subject | Memantine | Unknown | 5 mg | — |